Ken Griffin Prestige Consumer Healthcare Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$65.26 - $75.5 $319,774 - $369,950	4,900 Added 350.0%	6,300 $454,000
Q2 2024 Aug 14, 2024	SELL	$62.62 - $71.76 $6,262 - $7,176	-100 Reduced 6.67%	1,400 $96,000
Q1 2024 May 15, 2024	SELL	$58.76 - $75.07 $58,760 - $75,070	-1,000 Reduced 40.0%	1,500 $108,000
Q4 2023 Feb 14, 2024	SELL	$57.0 - $61.94 $96,900 - $105,298	-1,700 Reduced 40.48%	2,500 $153,000
Q3 2023 Nov 14, 2023	SELL	$56.7 - $68.29 $107,730 - $129,751	-1,900 Reduced 31.15%	4,200 $240,000
Q2 2023 Aug 14, 2023	BUY	$56.28 - $63.76 $292,656 - $331,552	5,200 Added 577.78%	6,100 $362,000
Q1 2023 May 15, 2023	BUY	$58.41 - $67.05 $52,569 - $60,345	900 New	900 $56,000

339

50.4M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $4.14B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.